Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Influenza

  Free Subscription


16.09.2019

1 Epidemiol Infect
2 J Immunol
3 J Infect Dis
2 J Virol
1 JAMA
2 Lancet Public Health
1 PLoS Comput Biol
4 PLoS One
9 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Epidemiol Infect

  1. SIMPSON RB, Alarcon Falconi TM, Venkat A, Chui KHH, et al
    Incorporating calendar effects to predict influenza seasonality in Milwaukee, Wisconsin.
    Epidemiol Infect. 2019;147:e268.
    PubMed     Text format     Abstract available


    J Immunol

  2. WANG X, Yuan J, Wang H, Gan N, et al
    Progranulin Decreases Susceptibility to Streptococcus pneumoniae in Influenza and Protects against Lethal Coinfection.
    J Immunol. 2019 Sep 13. pii: jimmunol.1900248. doi: 10.4049/jimmunol.1900248.
    PubMed     Text format     Abstract available

  3. PRICE MJ, Hicks SL, Bradley JE, Randall TD, et al
    IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes.
    J Immunol. 2019 Sep 9. pii: jimmunol.1900285. doi: 10.4049/jimmunol.1900285.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. LANGLEY JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, et al
    A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.
    J Infect Dis. 2018 Mar 30. pii: 4956800. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. STACEY HD, Miller MS
    Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
    J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
    PubMed     Text format    

  6. RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
    Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
    J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  7. YE L, Ohnemus A, Ong LC, Gad HH, et al
    Type I and type III interferons differ in their adjuvant activities for influenza vaccines.
    J Virol. 2019 Sep 11. pii: JVI.01262-19. doi: 10.1128/JVI.01262.
    PubMed     Text format     Abstract available

  8. WASIK BR, Voorhees IEH, Barnard KN, Alford-Lawrence BK, et al
    Influenza Viruses in Mice: Deep Sequencing Analysis of Serial Passage and Effects of Sialic Acid Structural Variation.
    J Virol. 2019 Sep 11. pii: JVI.01039-19. doi: 10.1128/JVI.01039.
    PubMed     Text format     Abstract available


    JAMA

  9. TALBOT TR, Babcock HM
    Respiratory Protection of Health Care Personnel to Prevent Respiratory Viral Transmission.
    JAMA. 2019;322:817-819.
    PubMed     Text format    


    Lancet Public Health

  10. LI L, Liu Y, Wu P, Peng Z, et al
    Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study.
    Lancet Public Health. 2019;4:e473-e481.
    PubMed     Text format     Abstract available

  11. HUO X, Zhu FC
    Influenza surveillance in China: a big jump, but further to go.
    Lancet Public Health. 2019;4:e436-e437.
    PubMed     Text format    


    PLoS Comput Biol

  12. VENKATRAMANAN S, Chen J, Fadikar A, Gupta S, et al
    Optimizing spatial allocation of seasonal influenza vaccine under temporal constraints.
    PLoS Comput Biol. 2019;15:e1007111.
    PubMed     Text format     Abstract available


    PLoS One

  13. YOUK S, Lee DH, Ferreira HL, Afonso CL, et al
    Rapid evolution of Mexican H7N3 highly pathogenic avian influenza viruses in poultry.
    PLoS One. 2019;14:e0222457.
    PubMed     Text format     Abstract available

  14. WANG W, Vassell R, Song HS, Chen Q, et al
    Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
    PLoS One. 2019;14:e0222436.
    PubMed     Text format     Abstract available

  15. CAINI S, Kusznierz G, Garate VV, Wangchuk S, et al
    The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
    PLoS One. 2019;14:e0222381.
    PubMed     Text format     Abstract available

  16. KRAMSKAYA T, Leontieva G, Desheva Y, Grabovskaya K, et al
    Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice.
    PLoS One. 2019;14:e0222148.
    PubMed     Text format     Abstract available


    Vaccine

  17. ELAISH M, Xia M, Ngunjiri JM, Ghorbani A, et al
    Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31171.
    PubMed     Text format     Abstract available

  18. HONEMANN M, Martin D, Pietsch C, Maier M, et al
    Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31091.
    PubMed     Text format     Abstract available

  19. QUATTROCCHI A, Mereckiene J, Fitzgerald M, Cotter S, et al
    Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31196.
    PubMed     Text format     Abstract available

  20. ARYA DP, Said MA, Izurieta HS, Perez-Vilar S, et al
    Surveillance for Guillain-Barre syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31109.
    PubMed     Text format     Abstract available

  21. RUDICELL RS, Garinot M, Kanekiyo M, Kamp HD, et al
    Comparison of adjuvants to optimize influenza neutralizing antibody responses.
    Vaccine. 2019;37:6208-6220.
    PubMed     Text format     Abstract available

  22. SMITH D, Streatfield SJ, Acosta H, Ganesan S, et al
    A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
    Vaccine. 2019;37:6162-6170.
    PubMed     Text format     Abstract available

  23. CHERIAN T, Morales KF, Mantel C, Lambach P, et al
    Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31000.
    PubMed     Text format     Abstract available

  24. NAKAMURA K, Harada Y, Takahashi H, Trusheim H, et al
    Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31140.
    PubMed     Text format     Abstract available

  25. COSTANTINO V, MacIntyre CR, Trent M
    Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31145.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: